Association of interferon-based therapy with risk of autoimmune diseases in patients with chronic hepatitis C virus infection: A population-based Taiwanese cohort study

por Chou, Shu-Ming, Yeh, Hsing-Jung, Lin, Tzu-Min, Chang, Yu-Sheng, Hsu, Hui-Ching, Shen, Yu-Chuan, Kuo, Tzu-Tung, Chen, Jin-Hua, Chen, Shu-Chuan, Chang, Chi-Ching
Publicado 2022

Proton Pump Inhibitors Increase the Risk of Autoimmune Diseases: A Nationwide Cohort Study

por Lin, Sheng-Hong, Chang, Yu-Sheng, Lin, Tzu-Min, Hu, Li-Fang, Hou, Tsung-Yun, Hsu, Hui-Ching, Shen, Yu-Chuan, Kuo, Pei-I, Chen, Wei-Sheng, Lin, Yi-Chun, Chen, Jin-Hua, Chang, Chi-Ching
Publicado 2021

H1-Antihistamines Reduce the Risk of Hepatocellular Carcinoma in Patients With Hepatitis B Virus, Hepatitis C Virus, or Dual Hepatitis B Virus-Hepatitis C Virus Infection

por Shen, Yu-Chuan, Hsu, Hui-Ching, Lin, Tzu-Min, Chang, Yu-Sheng, Hu, Li-Fang, Chen, Lung-Fang, Lin, Sheng-Hong, Kuo, Pei-I., Chen, Wei-Sheng, Lin, Yi-Chun, Chen, Jin-Hua, Liang, Yu-Chih, Chang, Chi-Ching
Publicado 2022